EU HEALTHCARE: Bayer (BAYNGR: Baa2 neg/BBB/BBB) Glyphosates
Limited impact
• In 2024, Glyphosate sales were 5.7% of total revenue.
• In 1Q25, 4.3%.
• North America is 41.6% of Crop Business sales.
• So, if Glyphosates were banned in the US tomorrow, sales would be impacted by less than 2.5%.
• No-one is talking about banning Glyphosates. The Kennedy report is said to recommend label warnings for consumers.
Want to read more?
Find more articles and bullets on these widgets:
Historical bullets
EQUITIES: US Opening calls
SPX: 5,465.3 (+1.9%); DJIA: 40,789 (+1.4%/+577pts); NDX: 19,120.3 (+2.3%).
EQUITY TECHS: E-MINI S&P: (M5) Corrective Cycle
- RES 4: 5906.75 High Mar 6
- RES 3: 5837.25 High Mar 25 and the reversal trigger
- RES 2: 5724.13 50-day EMA
- RES 1: 5512.18 20-day EMA
- PRICE: 5479.50 @ 14:10 BST Apr 14
- SUP 1: 5098.16 61.8% retracement of the Apr 7 - 10 bounce
- SUP 2: 4832.00 Low Apr 7 and the bear trigger
- SUP 3: 4760.88 1.618 proj of the Feb 19 - Mar 13 - 25 price swing
- SUP 4: 4663.75 1.764 proj of the Feb 19 - Mar 13 - 25 price swing
A short-term reversal in S&P E-Minis last week highlights the start of a corrective cycle. The trend condition has been oversold following recent weakness and the move higher is allowing this set-up to unwind. Initial resistance to watch is 5524.91, the 20-day EMA. Resistance at the 50-day EMA is at 5737.71. On the downside, key support and the bear trigger has been defined at 4832.00, the Apr 7 low.
EQUITIES: EU Bank outright call buyer
SX7E (20th June) 180c, bought for 4.25 in 12k vs 3.84k at 168.00.
